The last frontier: transcatheter devices for percutaneous or minimally invasive treatment of chronic heart failure.
Ontology highlight
ABSTRACT: Heart failure has a high prevalence in the general population. Morbidity and mortality of heart failure patients remain high, despite improvements in drug therapy, implantable cardioverter-defibrillators and cardiac resynchronisation therapy. New transcatheter implantable devices have been developed to improve the treatment of heart failure. There has been a rapid development of minimally invasive or transcatheter devices used in the treatment of heart failure associated with aortic and mitral valve disease and these devices are being incorporated into routine clinical practice at a fast rate. Several other new transcatheter structural heart interventions for chronic heart failure aimed at a variety of pathophysiologic approaches are currently being developed. In this review, we focus on d
SUBMITTER: Nijenhuis VJ
PROVIDER: S-EPMC5612866 | biostudies-literature | 2017 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA